Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific, Apogent Merger Gets FTC OK

NEW YORK, May 24 (GenomeWeb News) - Fisher Scientific and Apogent Technologies announced on Friday the expiration of the waiting period, required under US antitrust law, relating to their proposed $3.7 billion merger.


The companies said that the end of the waiting period indicates that the US Federal Trade Commission has completed its investigation into any potential antitrust violations associated with the deal and found that the companies meet all requirements.


The merger, first announced in March, is expected to close around July 1, said the companies.


The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.